insights_auto
Why is TNDM up 14.62%?
Dive Deeperchevron_right
TNDM:NASDAQ
Tandem Diabetes Care Inc
$20.07
arrow_upward
+14.62%(+2.56) 1D
$20.00
arrow_downward
-0.35% (-0.070)bedtimeAfter hours
Closed: Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNDM...
Open
$19.00
High
$20.26
Low
$17.48
Mkt. cap
1.40B
Avg. vol.
2.47M
Volume
4.40M
52-wk high
$29.65
52-wk low
$12.26
EPS
-$0.72
Beta
1.59
Shares outstanding
69.79M
No. of employees
2K
Open
$19.00
High
$20.26
Low
$17.48
Mkt. cap
1.40B
Avg. vol.
2.47M
Volume
4.40M
52-wk high
$29.65
52-wk low
$12.26
EPS
-$0.72
Beta
1.59
Shares outstanding
69.79M
No. of employees
2K
News stories
From web sources and news partners
GuruFocus
·
7 hours ago
Tandem Diabetes Care Inc (TNDM) Shares Surge 14.6% -- What GF Sc
Finimize
·
10 hours ago
Healthcare Stocks Ended Friday Higher On IPO Pop And FDA News
marketscreener.com
·
11 hours ago
Tandem Diabetes Care Shares Rise After Obtaining US FDA Clearance for Tubeless Automated Insulin Delivery System
BigGo Finance
·
12 hours ago
Tandem Wins FDA Nod for Tubeless Mobi Pump, Shares Climb 8%
Profile
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
About Tandem Diabetes Care Inc
CEOJohn Sheridan
Employees2.5K
FoundedJan 2006
Headquarters-
SectorHealth Care
IndustryMedical device
Websitetandemdiabetes.com